Serotonin or noradrenalin reuptake inhibition in seasonal affective disorder: escitalopram versus reboxetine

被引：0
|
作者：
Pjrek, E. [1 ]
Konstantinidis, A. [1 ]
Assem-Hilger, E. [2 ]
Praschak-Rieder, N. [1 ]
Willeit, M. [1 ]
Kasper, S. [1 ]
Winkler, D. [1 ]
机构：
[1] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria
[2] Med Univ Vienna, Dept Neurol, Vienna, Austria
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词：
OPEN TRIAL;
D O I：
10.1016/S0924-977X(09)70624-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S404 / S404
页数：1
相关论文
共 50 条
  • [1] Escitalopram versus reboxetine in the treatment of seasonal affective disorder
    Winkler, D.
    Pjrek, E.
    Willeit, M.
    Praschak-Rieder, N.
    Konstantinidis, A.
    Kasper, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S347 - S347
  • [2] Therapeutic effects of escitalopram and reboxetine in seasonal affective disorder: A pooled analysis
    Pjrek, Edda
    Konstantinidis, Anastasios
    Assem-Hilger, Eva
    Praschak-Rieder, Nicole
    Willeit, Matthaeus
    Kasper, Siegfried
    Winkler, Dietmar
    JOURNAL OF PSYCHIATRIC RESEARCH, 2009, 43 (08) : 792 - 797
  • [3] Reboxetine in seasonal affective disorder
    Hilger, E
    Willeit, M
    Praschak-Rieder, N
    Thierry, N
    Neumeister, A
    Stastny, J
    Freidl, M
    Daherova, N
    Kasper, S
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 77S - 77S
  • [4] Reboxetine in seasonal affective disorder: an open trial
    Hilger, E
    Willeit, M
    Praschak-Rieder, N
    Stastny, J
    Neumeister, A
    Kasper, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2001, 11 (01) : 1 - 5
  • [5] The norepinephrine reuptake inhibitor reboxetine is more potent in treating murine narcoleptic episodes than the serotonin reuptake inhibitor escitalopram
    Schmidt, Christian
    Leibiger, Judith
    Fendt, Markus
    BEHAVIOURAL BRAIN RESEARCH, 2016, 308 : 205 - 210
  • [6] Role of serotonin in seasonal affective disorder
    Gupta, A.
    Sharma, P. K.
    Garg, V. K.
    Singh, A. K.
    Mondal, S. C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (01) : 49 - 55
  • [7] Escitalopram in seasonal affective disorder: Results of an open trial
    Pjrek, E.
    Winkler, D.
    Stastny, J.
    Praschak-Rieder, N.
    Willeit, M.
    Kasper, S.
    PHARMACOPSYCHIATRY, 2007, 40 (01) : 20 - 24
  • [8] Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors
    Signorovitch, James
    Ramakrishnan, Karthik
    Ben-Hamadi, Rym
    Yu, Andrew P.
    Wu, Eric Q.
    Dworak, Heather
    Erder, M. Haim
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1089 - 1096
  • [9] Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis
    Lam, Raymond W.
    Loenn, Sara Larsson
    Despiegel, Nicolas
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2010, 25 (04) : 199 - 203
  • [10] Seasonal affective disorder and serotonin receptor polymorphisms.
    Johansson, C
    Smedh, C
    Partonen, T
    Ekholm, J
    Lichtermann, D
    Paunio, T
    Adolfsson, R
    Schalling, M
    MOLECULAR PSYCHIATRY, 1999, 4 : S90 - S91
12345